SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-19-119616
Filing Date
2019-04-25
Accepted
2019-04-25 16:04:03
Documents
5
Effectiveness Date
2019-04-25

Document Format Files

Seq Description Document Type Size
1 DEFA14A d679626ddefa14a.htm DEFA14A 18087
2 GRAPHIC g679626page003.jpg GRAPHIC 88019
3 GRAPHIC g679626page004.jpg GRAPHIC 147605
4 GRAPHIC g679626page005.jpg GRAPHIC 86646
5 GRAPHIC g679626page006.jpg GRAPHIC 9661
  Complete submission text file 0001193125-19-119616.txt   457398
Mailing Address 215 FIRST STREET CAMBRIDGE MA 02142
Business Address 215 FIRST STREET CAMBRIDGE MA 02142 617-299-8380
Sage Therapeutics, Inc. (Filer) CIK: 0001597553 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-36544 | Film No.: 19767410
SIC: 2834 Pharmaceutical Preparations